Committee Action
On February 14, 2024, the Subcommittee on Health held a
hearing on H.R. 7251. The title of the hearing was
``Legislative Proposals to Support Patients and Caregivers.''
The Subcommittee received testimony from:
Andy Shih, PhD, Chief Science Officer, Autism
Speaks;
Corey Feist, JD, MBA, Co-Founder and CEO, Dr.
Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and CEO, Alzheimer's
Association;
Gordon Tomaselli, MD, Former President, American
Heart Association; Marilyn and Stanley M. Katz Dean, Emeritus
and Professor of Medicine, Albert Einstein College of Medicine;
Adjunct Professor of Medicine, Johns Hopkins University School
of Medicine;
Michelle Whitten, President, CEO, and Co-Founder,
Global Down Syndrome Foundation;
Randy Strozyk, President, American Ambulance
Association; and
Christina Annunziata, MD, PhD, Senior Vice
President of Extramural Discovery Science, American Cancer
Society.
On March 12, 2024, the Subcommittee on Health met in open
markup session and forwarded H.R. 7251, as amended, to the full
Committee by a record vote of 23 yeas and 0 nays.
On March 20, 2024, the full Committee on Energy and
Commerce met in open markup session and ordered H.R. 7251, as
amended, favorably reported to the House by a record vote of 47
yeas and 0 nays.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to ensure
that communities and their health care professionals have the
resources to prevent and respond to poison emergencies.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 7251 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
hearing was used to develop or consider H.R. 7251:
On February 14, 2024, the Subcommittee on Health
held a hearing on H.R. 7251. The title of the hearing was
``Legislative Proposals to Support Patients and Caregivers.''
The Subcommittee received testimony from:
Andy Shih, PhD, Chief Science Officer,
Autism Speaks;
Corey Feist, JD, MBA, Co-Founder and
CEO, Dr. Lorna Breen Heroes' Foundation;
Joanne Pike, DrPH, President and CEO,
Alzheimer's Association;
Gordon Tomaselli, MD, Former President,
American Heart Association; Marilyn and Stanley M. Katz
Dean, Emeritus and Professor of Medicine, Albert
Einstein College of Medicine; Adjunct Professor of
Medicine, Johns Hopkins University School of Medicine;
Michelle Whitten, President, CEO, and
Co-Founder, Global Down Syndrome Foundation;
Randy Strozyk, President, American
Ambulance Association; and
Christina Annunziata, MD, PhD, Senior
Vice President of Extramural Discovery Science,
American Cancer Society.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 7251 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 provides that the Act may be cited as the
``Poison Control Centers Reauthorization Act of 2024''.
Section 2. Reauthorization of poison control programs
Section 2 reauthorizes certain poison control programs
through Fiscal Year 2029, including the national toll-free
poison control hotline and the grants for national poison
control center operations.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE XII--TRAUMA CARE
* * * * * * *
Part G--Poison Control
SEC. 1271. MAINTENANCE OF THE NATIONAL TOLL-FREE NUMBER AND OTHER
COMMUNICATION CAPABILITIES.
(a) In General.--The Secretary--
(1) shall provide coordination and assistance to
poison control centers for the establishment and
maintenance of a nationwide toll-free phone number, to
be used to access such centers; and
(2) may provide coordination and assistance to poison
control centers and consult with professional
organizations for the establishment, implementation,
and maintenance of other communication technologies to
be used to access such centers.
(b) Routing Contacts With Poison Control Centers.--Not later
than 18 months after the date of enactment of this subsection,
the Secretary shall coordinate with the Chairman of the Federal
Communications Commission, to the extent technically and
economically feasible, to ensure that communications with the
national toll-free number are routed to the appropriate poison
control center based on the physical location of the contact
rather than the area code of the contact device.
(c) Authorization of Appropriations.--There is authorized to
be appropriated to carry out this section, $700,000 for each of
[fiscal years 2020 through 2024] fiscal years 2025 through 2029
for the establishment, implementation, and maintenance
activities carried out under subsections (a) and (b).
SEC. 1272. PROMOTING POISON CONTROL CENTER UTILIZATION.
(a) In General.--The Secretary shall carry out, and expand
upon, a national media campaign to educate and support outreach
to the public and health care providers about poisoning and
toxic exposure prevention and the availability of poison
control center resources in local communities and to conduct
advertising campaigns concerning the nationwide toll-free
number and other available communication technologies
established, implemented, or maintained under section 1271(a).
(b) Contract With Entity.--The Secretary may carry out
subsection (a) by entering into contracts with one or more
public or private entities, including nationally recognized
organizations in the field of poison control and national media
firms, for the development and implementation of a nationwide
poisoning and toxic exposure prevention and poison control
center awareness campaign, which may include--
(1) the development and distribution of poisoning and
toxic exposure prevention awareness materials,
applicable public health emergency preparedness and
response information, and poison control center
awareness materials;
(2) television, radio, Internet, and newspaper public
service announcements; and
(3) other activities to provide for public and
professional awareness and education.
(c) Authorization of Appropriations.--There is authorized to
be appropriated to carry out this section, $800,000 for each of
[fiscal years 2020 through 2024] fiscal years 2025 through
2029.
SEC. 1273. MAINTENANCE OF THE POISON CONTROL CENTER GRANT PROGRAM.
(a) Authorization of Program.--The Secretary shall award
grants to poison control centers accredited under subsection
(c) (or granted a waiver under subsection (d)) and professional
organizations in the field of poison control for the purposes
of preventing, and providing treatment recommendations for,
poisonings and toxic exposures and complying with the
operational requirements needed to sustain the accreditation of
the center under subsection (c).
(b) Additional Uses of Funds.--In addition to the purposes
described in subsection (a), a poison center or professional
organization awarded a grant, contract, or cooperative
agreement under such subsection may also use amounts received
under such grant, contract, or cooperative agreement--
(1) to research, establish, implement, and evaluate
best practices in the United States for poisoning and
toxic exposure prevention, poison control center
outreach, and emergency preparedness and response
programs;
(2) to research, develop, implement, revise, and
communicate standard patient management guidelines for
commonly encountered toxic exposures;
(3) to improve national toxic exposure surveillance
by enhancing cooperative activities between poison
control centers in the United States, the Centers for
Disease Control and Prevention, and other government
agencies as determined to be appropriate and
nonduplicative by the Secretary;
(4) to research, improve, and enhance the
communications and response capability and capacity of
the nation's network of poison control centers to
facilitate increased access to the centers through the
integration and modernization of the current poison
control centers communications and data system,
including enhancing the network's telephony, Internet,
data and social networking technologies;
(5) to develop, support, and enhance technology and
capabilities of professional organizations in the field
of poison control to collect national poisoning, toxic
occurrence, and related public health data;
(6) to develop initiatives to foster the enhanced
public health utilization of national poison data
collected by organizations described in paragraph (5);
(7) to support and expand the toxicologic expertise
within poison control centers; and
(8) to improve the capacity of poison control centers
to answer high volumes of contacts and Internet
communications, and to sustain and enhance the poison
control center's network capability to respond during
times of national crisis or other public health
emergencies.
(c) Accreditation.--Except as provided in subsection (d), the
Secretary may award a grant to a poison control center under
subsection (a) only if--
(1) the center has been accredited by a professional
organization in the field of poison control, and the
Secretary has approved the organization as having in
effect standards for accreditation that reasonably
provide for the protection of the public health with
respect to poisoning; or
(2) the center has been accredited by a State
government, and the Secretary has approved the State
government as having in effect standards for
accreditation that reasonably provide for the
protection of the public health with respect to
poisoning.
(d) Waiver of Accreditation Requirements.--
(1) In general.--The Secretary may grant a waiver of
the accreditation requirements of subsection (c) with
respect to a nonaccredited poison control center that
applies for a grant under this section if such center
can reasonably demonstrate that the center will obtain
such an accreditation within a reasonable period of
time as determined appropriate by the Secretary.
(2) Renewal.--The Secretary may renew a waiver under
paragraph (1).
(3) Limitation.--
(A) In general.--The sum of the number of
years for a waiver under paragraph (1) and a
renewal under paragraph (2) may not exceed 5
years.
(B) Public health emergency.--Notwithstanding
any previous waivers, in the case of a poison
control center whose accreditation is affected
by a public health emergency declared pursuant
to section 319, the Secretary may, as the
circumstances of the emergency reasonably
require, provide a waiver under paragraph (1)
or a renewal under paragraph (2), not to exceed
2 years. The Secretary may require quarterly
reports and other information related to such a
waiver or renewal under this paragraph.
(e) Supplement Not Supplant.--Amounts made available to a
poison control center under this section shall be used to
supplement and not supplant other Federal, State or local funds
provided for such center.
(f) Maintenance of Effort.--With respect to activities for
which a grant is awarded under this section, the Secretary may
require that poison control centers agree to maintain the
expenditures of the center for such activities at a level that
is not less than the level of expenditures maintained by the
center for the fiscal year preceding the fiscal year for which
the grant is received.
(g) Authorization of Appropriations.--There is authorized to
be appropriated to carry out this section, $28,600,000 for each
of [fiscal years 2020 through 2024] fiscal years 2025 through
2029. The Secretary may utilize an amount not to exceed 6
percent of the amount appropriated under this preceding
sentence in each fiscal year for coordination, dissemination,
technical assistance, program evaluation, data activities, and
other program administration functions, which are determined by
the Secretary to be appropriate for carrying out the program
under this section.
(h) Biennial Report to Congress.--Not later than 2 years
after the date of enactment of this subsection, and every 2
years thereafter, the Secretary shall submit to the Committee
on Health, Education, Labor, and Pensions of the Senate and
Committee on Energy and Commerce of the House of
Representatives a report concerning the operations of, and
trends identified by, the Poison Control Network. Such report
shall include--
(1) descriptions of the activities carried out
pursuant to sections 1271, 1272, and 1273, and the
alignment of such activities with the purposes provided
under subsection (a);
(2) a description of trends in volume of contacts to
poison control centers;
(3) a description of trends in poisonings and toxic
exposures reported to poison control centers, as
applicable and appropriate;
(4) an assessment of the impact of the public
awareness campaign, including any geographic
variations;
(5) a description of barriers, if any, preventing
poison control centers from achieving the purposes and
programs under this section and sections 1271 and 1272;
(6) a description of the standards for accreditation
described in subsection (c), including any variations
in those standards, and any efforts to create and
maintain consistent standards across organizations that
accredit poison control centers; and
(7) the number of and reason for any waivers provided
under subsection (d).
* * * * * * *
[all]